Cross-sectional study of the effectiveness and safety of proton beam therapy for liver metastatic 3 or less lesions in gastric cancer patients without extrahepatic lesion

Cross-sectional study of the effectiveness and safety of proton beam therapy for liver metastatic 3 or less lesions in gastric cancer patients without extrahepatic lesion - Cross-sectional study of the effectiveness and safety of proton beam therapy for liver metastatic 3 or less lesions in gastric cancer patients without extrahepatic lesion

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041791

Enrollment

Registered

2020-09-15

Start date

2018-04-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Diagnosed adenocarcinoma after R0 gastrectomy 2.Liver metastasis from gastric cancer patients without extrahepatic metastatic lesions 3.Patients completed proton beam therapy without interruption

Exclusion criteria

Exclusion criteria: 1.Patients without follow-up data

Design outcomes

Primary

Measure	Time frame
1. Local control rates 2. Overall survival rates 3. Progression-free survival rates 4. Adverse events	—

Countries

Japan

Contacts

Public ContactHisashi Yamaguchi

Southern Tohoku Proton Beam Therapy Center Department of radiology

hisashi.yamaguchi@mt.strins.or.jp024-934-3888

Outcome results